US WorldMeds Revenue and Competitors
Estimated Revenue & Valuation
- US WorldMeds's estimated annual revenue is currently $23.9M per year.
- US WorldMeds's estimated revenue per employee is $234,500
- US WorldMeds has 102 Employees.
- US WorldMeds grew their employee count by 1% last year.
US WorldMeds Competitors & AlternativesAdd Company
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is US WorldMeds?
US WorldMeds is a specialty pharmaceutical company that develops, licenses, and brings to market unique healthcare products designed to improve the lives of patients with challenging conditions and unmet medical needs. Organized on March 23, 2001 by current CEO Paul Breckinridge "Breck" Jones, US WorldMeds holds true to Breck's vision of creating a sustainable, privately held specialty pharmaceutical company known for agility and personal attention to its products and stakeholders. Our dedication to improving patients lives can be seen both in the products that we market and the therapies that are currently under development. Each day, we work diligently to bring new therapies and new indications to patients across multiple therapeutic areas. In addition to our dedication to serving patients, we embrace a culture that values honesty, creativity, and action, integrity in relationships, a passion for success, and good stewardship of Company resources. We offer our employees exciting challenges, unique opportunities, and a fast-paced environment that emphasizes innovation and achievement. Our headquarters are in Louisville, Kentucky, but you can find our team and partners throughout the U.S. and across the globe. To learn more about our mission and values, and for all US WorldMeds information, visit our site: http://www.usworldmeds.com. You can also follow us on Twitter at @USWorldMeds.keywords:Biotechnology,Healthcare,Pharmaceuticals
Number of Employees
Employee Growth %
US WorldMeds News
US WorldMeds is a privately held specialty pharmaceutical company that develops, licenses, and markets unique healthcare products designed to...
US WorldMeds markets and distributes SYMJEPI in the United States. School voucher bill fails in late-night Oklahoma Senate vote.
US WorldMeds has been the marketer and distributor of Symjepi in the U.S. since mid-2020, when Adamis took back the rights from Novartis' Sandoz and...
Louisville-based pharmaceutical company US WorldMeds LLC received Food and Drug Administration approval for a new use of its drug ...
Specialty pharma company US WorldMeds has had its supplemental Biologics License Application (sBLA) approved for Myobloc ...
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|